Silence Therapeutics plc（SLN）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · SLN · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$0.56M	$43.26M	$25.38M	$17.65M	$12.41M
Cost of Revenue	$0.21M	$11.81M	$10.32M	$10.97M	$7.46M
Gross Profit	$0.34M	$31.45M	$15.06M	$6.68M	$4.96M
Gross Margin %(computed)	61.54%	72.70%	59.34%	37.83%	39.94%
Operating Expenses
R&D Expenses	$67.75M	$67.88M	$44.02M	$35.50M	$30.77M
G&A Expenses	$22.34M	$26.88M	$20.64M	$20.94M	$20.01M
Total Operating Expenses	$90.10M	$94.77M	$64.66M	$56.44M	$50.77M
Operating Income	($89.75M)	($63.32M)	($49.60M)	($49.76M)	($45.81M)
Operating Margin %(computed)	—	-146.38%	-195.48%	-281.87%	-369.02%
Interest Income	$3.48M	$4.47M	$1.45M	$0.23M	$0.01M
Interest Expense	$0.00M	$0.00M	$0.03M	$0.05M	$0.01M
Income Before Tax	($88.60M)	($44.46M)	($50.31M)	($40.47M)	($45.86M)
Income Tax Expense	$0.01M	$0.84M	($7.04M)	$0.56M	($6.45M)
Net Income	($88.61M)	($45.31M)	($43.27M)	($41.03M)	($39.41M)
Net Margin %(computed)	—	-104.74%	-170.51%	-232.44%	-317.44%
Per Share & EBITDA
EPS (Basic)	$-1.89	$-2.37	$-3.48	$-3.78	$-1.35
Wtd Avg Shares	47.23M	15.42M	12.36M	10.73M	29.65M
EBITDA	($89.20M)	($48.99M)	($49.78M)	($49.27M)	($45.42M)
EBITDA Margin %(computed)	—	-113.25%	-196.17%	-279.12%	-365.86%